Dr. Ghiuzeli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Seattle Cancer Care Alliance
825 Eastlake Ave East
Seattle, WA 98109Phone+1 206-606-4051
Summary
- Dr. Cristina Maria Ghiuzeli is an hematologist at SCCA (Seattle Cancer Care Alliance) in Seattle, Washington. She specializes in treatment of myeloid malignancies (acute myeloid leukemia, MDS, aplastic anemia, and myeloproliferative neoplasms) and acute lymphoblastic leukemia.
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2006 - 2009
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
- Albert Einstein College of MedicineClass of 2003
Certifications & Licensure
- WA State Medical License 2020 - 2025
- NY State Medical License 2006 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Start of enrollment: 2008 Jan 15
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Publications & Presentations
PubMed
- 3 citationsHyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.Lucas C Zarling, Philip A Stevenson, Lorinda A Soma, Christen H Martino, Mary-Elizabeth M Percival
European Journal of Haematology. 2023-12-01 - 2 citationsPhase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival
Blood Advances. 2023-09-12 - 8 citationsSuccessful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer.Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, Ryan D Cassaday, Guang-Shing Cheng
Open Forum Infectious Diseases. 2023-06-01
Press Mentions
- Tip Sheet: Funding Awarded to Two Ovarian Cancer Research Projects, Progress Towards Liquid Biopsies for Lung Cancer — and Cannabis and Alcohol Use in PatientsMay 3rd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: